BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35882984)

  • 1. Conjunctival Lymphoma.
    McGrath LA; Ryan DA; Warrier SK; Coupland SE; Glasson WJ
    Eye (Lond); 2023 Apr; 37(5):837-848. PubMed ID: 35882984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
    Celiker H; Toker E; Kaygusuz Atagunduz I
    Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favourable response to rituximab by an ocular adnexal primary lymphoma.
    Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
    Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant lymphoma of the conjunctiva.
    Kirkegaard MM; Coupland SE; Prause JU; Heegaard S
    Surv Ophthalmol; 2015; 60(5):444-58. PubMed ID: 26003619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
    Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
    Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
    Nückel H; Meller D; Steuhl KP; Dührsen U
    Eur J Haematol; 2004 Oct; 73(4):258-62. PubMed ID: 15347312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital Lymphoma-An International Multicenter Retrospective Study.
    Olsen TG; Holm F; Mikkelsen LH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Sjö LD; Vemuganti GK; Thuro BA; Heegaard S
    Am J Ophthalmol; 2019 Mar; 199():44-57. PubMed ID: 30419193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular adnexal lymphoma: Subtype-specific clinical and genetic features.
    Kirkegaard MK
    Acta Ophthalmol; 2022 Oct; 100 Suppl 270():3-37. PubMed ID: 36196757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
    Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
    Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa.
    Nam SW; Woo KI; Kim YD
    Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salmon-pink colored conjunctival tumor with amyloid deposits].
    Müller PL; Loeffler KU; Holz FG; Fischer HP; Herwig MC
    Ophthalmologe; 2016 Jul; 113(7):602-5. PubMed ID: 26362570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
    Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
    Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Conjunctival Extranodal Marginal Zone Lymphoma Treated with Intralesional Rituximab Injection Therapy.
    Yazicioglu T; Oklar M; Kocabas S; Karadag E; Elibol V; Tezcan ME
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1329-1333. PubMed ID: 36084297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia?
    Beykin G; Pe'er J; Amir G; Frenkel S
    Br J Ophthalmol; 2014 May; 98(5):645-50. PubMed ID: 24162623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
    Coupland SE
    Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture.
    Shields CL; Chien JL; Surakiatchanukul T; Sioufi K; Lally SE; Shields JA
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):109-120. PubMed ID: 28399347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.